GlassScriptPhysician profile
Maheshkumar P Mehta
NPI 1326139726
$660.28
in general payments reported to CMS, 2019-2025
12 companies · $74.34 in 2025
The $74.34 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $79.41 · 2025: $74.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $226.81 | 2019 | |
| Mdd US Operations, LLC | $125.00 | 2019 | |
| Collegium Pharmaceutical, INC. | $73.99 | 2019-2020 | |
| Nevro Corp. | $58.27 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $58.09 | 2025 | |
| Biodelivery Sciences International, INC. | $23.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.39 | 2019 | |
| Baudax Bio INC. | $17.22 | 2020 | |
| Epimed International, INC | $16.37 | 2019 | |
| Teleflex LLC | $16.25 | 2025 | Rusch |
| Astrazeneca Pharmaceuticals LP | $13.51 | 2019 | |
| Scilex Pharmaceuticals INC. | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maheshkumar Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.